Skip to main navigation Skip to search Skip to main content

Spontaneous tumor lysis syndrome in a patient with metastatic small cell carcinoma of the lung

  • West Penn Allegheny Health System

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

Tumor lysis syndrome (TLS) is a life-threatening condition which could result in electrolyte imbalances, acute renal failure, seizures, arrhythmias and sudden death. It is mostly seen after the initiation of chemotherapy in hematological malignancies such as Burkitt's lymphoma and other Non-Hodgkin's Lymphoma. Solid tumors are rarely associated with Tumor Lysis Syndrome. TLS prior to the initiation of chemotherapy is known as spontaneous TLS, of which most of the literature involves hematological malignancies. There have been only a handful of case reports of spontaneous TLS occurring in solid tumors. We are presenting a patient who was newly diagnosed with metastatic small cell cancer of lung who developed spontaneous TLS. To our knowledge this is the first reported case of spontaneous TLS in small cell cancer of the lung. We will also review the literature on spontaneous TLS in solid tumors and whether as clinicians we can identify high-risk patients. Prompt diagnosis is essential in order to initiate necessary prophylactic precautions. After reviewing the few case reports it appears bulky tumors, site of metastases, prior renal functions may predict risk of suffering from TLS in solid tumors.

Original languageEnglish
Pages (from-to)164-166
Number of pages3
JournalJournal of Cancer Science and Therapy
Volume4
Issue number6
DOIs
StatePublished - 2012

Keywords

  • Acute renal failure
  • Chemotherapy
  • Small cell cancer of lung
  • Solid tumors
  • Spontaneous tumor lysis syndrome

Fingerprint

Dive into the research topics of 'Spontaneous tumor lysis syndrome in a patient with metastatic small cell carcinoma of the lung'. Together they form a unique fingerprint.

Cite this